Greenleaf Trust’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.79M Sell
25,560
-2,048
-7% -$143K 0.02% 217
2025
Q1
$2.03M Buy
27,608
+504
+2% +$37K 0.02% 195
2024
Q4
$1.78M Buy
27,104
+1,210
+5% +$79.3K 0.02% 214
2024
Q3
$2.02M Buy
25,894
+50
+0.2% +$3.9K 0.02% 203
2024
Q2
$2.02M Buy
25,844
+34
+0.1% +$2.65K 0.02% 180
2024
Q1
$1.75M Sell
25,810
-1,885
-7% -$128K 0.02% 199
2023
Q4
$1.87M Sell
27,695
-1,500
-5% -$101K 0.02% 185
2023
Q3
$1.98M Sell
29,195
-5,607
-16% -$380K 0.02% 163
2023
Q2
$2.49M Buy
34,802
+726
+2% +$52K 0.03% 139
2023
Q1
$2.37M Buy
34,076
+2,774
+9% +$193K 0.03% 146
2022
Q4
$2.12M Sell
31,302
-181
-0.6% -$12.3K 0.03% 153
2022
Q3
$1.73M Sell
31,483
-515
-2% -$28.3K 0.03% 166
2022
Q2
$2.11M Buy
31,998
+6,354
+25% +$420K 0.03% 129
2022
Q1
$1.7M Sell
25,644
-1,692
-6% -$112K 0.02% 160
2021
Q4
$1.59M Buy
27,336
+16
+0.1% +$932 0.02% 167
2021
Q3
$1.64M Buy
27,320
+1,292
+5% +$77.6K 0.02% 148
2021
Q2
$1.56M Sell
26,028
-331
-1% -$19.8K 0.02% 162
2021
Q1
$1.31M Sell
26,359
-1,221
-4% -$60.7K 0.02% 168
2020
Q4
$1.38M Sell
27,580
-302
-1% -$15.1K 0.02% 140
2020
Q3
$1.53M Buy
27,882
+775
+3% +$42.5K 0.02% 121
2020
Q2
$1.43M Buy
27,107
+1,572
+6% +$83.2K 0.03% 121
2020
Q1
$1.14M Buy
25,535
+2,734
+12% +$122K 0.02% 122
2019
Q4
$1.14M Sell
22,801
-667
-3% -$33.3K 0.02% 153
2019
Q3
$1.05M Buy
23,468
+1,365
+6% +$60.8K 0.02% 156
2019
Q2
$912K Buy
22,103
+527
+2% +$21.7K 0.01% 176
2019
Q1
$872K Sell
21,576
-5,990
-22% -$242K 0.01% 176
2018
Q4
$1.05M Buy
27,566
+960
+4% +$36.5K 0.02% 148
2018
Q3
$1.05M Buy
26,606
+1,486
+6% +$58.8K 0.02% 166
2018
Q2
$882K Buy
25,120
+8,670
+53% +$304K 0.02% 178
2018
Q1
$575K Buy
16,450
+1,286
+8% +$45K 0.01% 221
2017
Q4
$526K Buy
15,164
+6,440
+74% +$223K 0.01% 239
2017
Q3
$296K Sell
8,724
-3,076
-26% -$104K 0.01% 312
2017
Q2
$402K Buy
+11,800
New +$402K 0.01% 232